Informa
TIDES Asia: Oligonucleotide & Peptide Therapeutics
2025年2月26-28日
日本京都, Westin Miyako Kyoto

主會議 第2天

主會議 第2天

7:45am - 8:10am25分鐘
Registration and Coffee
報到・咖啡時光
    8:10am - 8:15am5分鐘
    Chairperson’s Remarks: Plenary Day 2
    主席致辭：主題講演（第2天）
      8:15am - 8:45am30分鐘
      Morning Spotlight Presentation: Isolation and Drying of Peptides and 0ligonucleotides - Improved Production Capacities During Large Scale Manufacturing
      晨間焦點簡報：胜肽和寡核苷酸的分離和乾燥—提高大規模生產過程中的生產能力
      • Keith Cronce - Chief Operating Officer, Fluid Air, A Division of Spraying Systems
      Plenary Session
      主題講演單元
      8:45am - 9:15am30分鐘
      Plenary Session
      主題講演單元
      Complete Chemical Synthesis of mRNA for Cancer Vaccine
      癌症疫苗 mRNA 的完整化學合成
      • Hiroshi Abe, PhD - Professor, Department of Chemistry, Graduate School, Nagoya University
      9:15am - 9:45am30分鐘
      Plenary Session
      主題講演單元
      Developing the Next Generation RSV Vaccine
      下一代 RSV 疫苗的開發
      • Dong Shen, MD, PhD - CEO, RNAimmune, Inc.
      9:45am - 10:15am30分鐘
      Plenary Session
      主題講演單元
      RNA Therapy for Asthma
      哮喘的 RNA 療法
      • Thomas Langenickel, MD, PhD - Chief Medical Officer, Ethris GmbH
      10:15am - 10:55am40分鐘
      Networking Refreshment Break with Poster and Exhibit Viewing
      互動交流休息時間，觀賞海報和展覽
        Concurrent Conference Tracks
        同時進行的各個分會
        10:55am - 11:00am5分鐘
        Track 1: Oligonucleotides
        分會1：寡核苷酸
        Chairperson’s Remarks: Track 1
        主席致辭：分會1
        • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
        10:55am - 11:00am5分鐘
        Track 2: Peptides
        分會2：胜肽
        Chairperson’s Remarks: Track 2
        主席致辭：分會2
        • El Djouhar Rekai, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
        11:00am - 11:30am30分鐘
        Track 1: Oligonucleotides
        分會1：寡核苷酸
        CMC Strategies for the Characterization of Stereopure Platform Chemistry
        用於表徵立體純平台化學的 CMC 策略
        • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
        11:00am - 11:30am30分鐘
        Track 2: Peptides
        分會2：胜肽
        Industry Perspective on the Selection of Regulatory Starting Materials for Synthetic Peptides
        關於如何選擇監管對象合成肽起始材料的業界見解
        • John Lopez, PhD - Associate Director Science & Technology, Novartis
        11:30am - 12:00pm30分鐘
        Track 1: Oligonucleotides
        分會1：寡核苷酸
        Template-independent Enzymatic Synthesis of Natural and Fully Modified siRNA Oligonucleotides
        天然/完全修飾的 siRNA 寡核苷酸的不依賴模板的酶合成
        • Jonathan Rittichier, PhD - Chief Scientific Officer & Co-Founder, EnPlusOne BioSciences
        11:30am - 12:00pm30分鐘
        Track 2: Peptides
        分會2：胜肽
        Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase
        原料藥中的雜質以及申請（美國、歐盟、巴西和中國市場）和商業化階段面臨的課題
        • Dinesh Parmar - Associate Director Regulatory Affairs, PolyPeptide Group
        12:00pm - 12:30pm30分鐘
        Track 1: Oligonucleotides
        分會1：寡核苷酸
        Synthesis of Nucleic Acid Therapeutics: Next Generation Processes and Solutions
        核酸治療藥物的合成：下一代製程和解決方案
        • Sirat Sikka - Senior Scientist, Applications and Innovation, Thermo Fisher Scientific
        12:00pm - 12:30pm30分鐘
        Track 2: Peptides
        分會2：胜肽
        Statistical Design of Experiments in Peptide Process Development
        胜肽製程開發中實驗的統計設計
        • Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
        12:30pm - 1:40pm70分鐘
        Networking Luncheon with Poster and Exhibit Viewing
        交流時間・午餐會，觀賞海報和展覽
          1:40pm - 1:45pm5分鐘
          Track 1: Oligonucleotides
          分會1：寡核苷酸
          Chairperson’s Remarks: Track 1
          主席致辭：分會1
          • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
          1:40pm - 1:45pm5分鐘
          Track 2: Peptides
          分會2：胜肽
          Chairperson’s Remarks: Track 2
          主席致辭：分會2
            1:45pm - 2:15pm30分鐘
            Track 1: Oligonucleotides
            分會1：寡核苷酸
            Drug Substance and Drug Product CMC Strategies for Start-Ups and Smaller Companies
            新創公司和小型公司的原料藥和藥品 CMC 策略
            • Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
            1:45pm - 2:15pm30分鐘
            Track 2: Peptides
            分會2：胜肽
            Development of an Efficient and Scalable CSPS Process for a Mid-Sized Cyclic Peptide
            開發適用於中型環肽的高效且可擴大縮小的 CSPS 製程
            • Hiroshi Iwamura, PhD - Deputy Head of API Process Development Department, Chugai Pharmaceutical Co., Ltd.
            2:15pm - 2:45pm30分鐘
            Track 1: Oligonucleotides
            分會1：寡核苷酸
            Oligonucleotide API Quality
            寡核苷酸API的品質
              2:15pm - 2:45pm30分鐘
              Track 2: Peptides
              分會2：胜肽
              Overcoming Aggregation Challenges in Peptide Manufacturing: Technical Approach and Case Studies
              克服胜肽生產過程中的聚集問題：技術方法與案例研究
              • El Djouhar Rekai, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
              2:45pm - 3:15pm30分鐘
              Track 1: Oligonucleotides
              分會1：寡核苷酸
              Oligonucleotide Process Validation
              寡核苷酸製程驗證
                2:45pm - 3:15pm30分鐘
                Track 2: Peptides
                分會2：胜肽
                An Inline Monitoring Method Integrated Flow Chemistry for Peptide Synthesis and Manufacturing
                用於胜肽合成和製造的整合流動化學線上監測方法
                • Pengyu Xu, PhD - President and Representative Director, SynCrest Inc.
                3:15pm - 3:45pm30分鐘
                Networking Refreshment Break with Poster and Exhibit Viewing
                互動交流休息時間，觀賞海報和展覽
                  3:45pm - 4:15pm30分鐘
                  Track 1: Oligonucleotides
                  分會1：寡核苷酸
                  Development of a Kilogram-Scale Manufacturing Route for Guadecitabine: A Dinucleotide DNA Methyltransferase Inhibitor
                  Guadecitabine公斤級生產方法的開發：一種二核苷酸 DNA 甲基轉移酶抑製劑
                  • Yogesh Sanghvi, PhD - President, Rasayan Inc.
                  3:45pm - 4:15pm30分鐘
                  Track 2: Peptides
                  分會2：胜肽
                  GLP-1 Process Development and Manufacturing
                  GLP-1工程的開發與製造
                    4:15pm - 4:45pm30分鐘
                    Track 1: Oligonucleotides
                    分會1：寡核苷酸
                    Analytical Strategies for RNA Therapeutics
                    RNA治療藥的分析策略
                      4:15pm - 4:45pm30分鐘
                      Track 2: Peptides
                      分會2：胜肽
                      Liquid-phase Peptide Fragment Manufacturing Technologies and Workflows
                      液相肽片段的生產技術和工作流程
                      • Adrian Amador, PhD - Director of Process Chemistry, Cambrex
                      4:45pm - 5:15pm30分鐘
                      Track 1: Oligonucleotides
                      分會1：寡核苷酸
                      Oligonucleotide Purification and CMC Strategies - Increasing Efficiencies/Overcoming Challenges
                      寡核苷酸純化和 CMC 策略：提高效率並克服課題
                      • Robert Gronke, PhD - Senior Principal Scientist, Technical Development, Biogen, Inc
                      4:45pm - 5:15pm30分鐘
                      Track 2: Peptides
                      分會2：胜肽
                      Late Breaking Presentation
                      發表最新成果
                        5:15pm - 6:15pm60分鐘
                        Networking Cocktail Reception with Poster and Exhibit Viewing
                        社交雞尾酒會，觀賞海報和展覽
                          6:15pm - 6:20pm5分鐘
                          Close of Day Two
                          第2天結束
                            會前研討會 (上午) & 主會議 第1天 (下午)
                            Next主會議 第3天

                            * 活動內容有可能不事先告知作更動及調整。